News
GSK is a remedy for the winter investment blahs
GSK (NYSE: GSK) is not immune to the patent cliff faced by the pharmaceutical industry, but it is about as well prepared as it can be. The company faces a smaller impact than others, has years to
Outcrop Silver & Gold nimmt am Precious Metals Summit Zurich teil
Vancouver, British Columbia--(25. Oktober 2023) - Outcrop Silver & Gold (TSXV: OCG) (OTCQX: OCGSF) freut sich bekannt zu geben, dass das Unternehmen am Precious Metals Summit Zurich 2023
Outcrop Silver & Gold to Present at Precious Metals Summit Zurich
Vancouver, British Columbia--(October 25, 2023) - Outcrop Silver & Gold (TSXV: OCG) (OTCQX: OCGSF) is pleased to announce its participation at the 2023 Precious Metals Summit Zurich where it
2 Mega Caps With Comeback Rallies About To Start
After a stellar first half to the year, especially when compared to last year's bloodbath, the S&P 500 index has been trending down since August. Friday was its third big down day in a row, and by
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?
Very rarely do investors get the opportunity to consider a purchase of a high-quality asset or company at a steep discount to the overall industry it operates within. Today, there is not only one
5 High-Yielding S&P Stocks: Is It The Right Time To Buy?
About three-fourths of the S&P 500 pay a dividend. According to S&P Dow Jones Indices, dividends have contributed approximately 32% of total S&P return since 1926.
The current yield of the S&P
Are High-Yielding AT&T And Verizon Worth Buying As Prices Skid?
Oh, how the mighty have fallen. Back in the days when people talked of so-called “blue chip” stocks, those that seemingly could do no wrong, America’s telecom stock was AT&T Inc. (NYSE: T).
But
Are foreign investments in Botswana's mining sector still safe?
Brandenburg, August 14, 2023 - Botswana is one of the most stable and transparent countries in Africa. The government of Botswana is committed to diversifying its economy and securing more
Drinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners
Global financial crises. A pandemic. Recession. Countless geopolitical conflicts.
A lot has happened over the last 10 years.
The U.S. stock market has been rattled by a range of events and yet
Can the Amazon Partnership Put DISH Network Back on Track?
Satellite TV and wireless provider DISH Network Co. (NASDAQ: DISH) stock surged higher on news of a partnership to sell mobile services to Amazon Prime members. DISH is one of the few mainstream
Is AT&T Stock a Golden Opportunity or 'Lead' Weight?
AT&T Inc. (NYSE:T) is being haunted by a ghost of telecommunications past.
Emerging concerns about the lead content of the industry’s legacy cables spooked environmentalists and investors alike
Viasat Drops 29%: Falling Knife or Moonshot Bargain?
Last month, digital satellite telecommunications pioneer Viasat, Inc. (NASDAQ: VSAT) was on top of the world. The company had just wrapped up a $7.3 billion acquisition of U.K. rival Inmarsat to
Drugmaker GSK: Becoming a Healthier Value Stock
Like most stocks during the dot-com bubble, GSK PLC (NYSE: GSK) partied like it was 1999. In the two decades since, missteps and competitive pressures slashed roughly 50% from the U.K. pharmaceuti
T-Mobile Stock's Decline: Does Value Potential Exist?
Investors rarely get to consider a blue-chip company like T-Mobile US (NASDAQ: TMUS) amid a decline of more than 17% during the past two months. As the underlying stock carries a beta of only
Eagle Materials, Answering America's Building Supply Needs
Shares of Eagle Materials (NYSE: EXP) are rallying in the pre-market hours of Thursday morning as the company releases its quarterly earnings results, which delivered an exceptional quarter
Are Rising Interest Rates Killing AT&T Stock?
Telecom giant AT&T Inc. (NYSE: T) spun off its Warnermedia division to merge with Discovery Networks to form Warner Bros. Discovery Inc. (NYSE: WBD) to reduce some of its massive debt load. AT&T
ADC Therapeutics nimmt am Guggenheim 5th Annual Healthy Altitudes Summit teil
LAUSANNE, Schweiz, March 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) gab heute bekannt, dass Ameet Mallik, Chief Executive Officer, an einem Kamingespräch auf dem Guggenheim 5th
Haupterkenntnisse des DACH Healthcare Innovation Summit: Mehr Zusammenarbeit, Interoperabilität und Technologie zur Verbesserung der Reaktionsfähigkeit von Gesundheitssystemen
Bamberg Health hat soeben ein kostenloses Schlussdokument mit den Höhepunkten des DACH Healthcare Innovation Summit veröffentlicht, der letzten Monat in Berlin stattfand.
BERLIN, Feb. 27, 2024
MetrioPharm veröffentlicht Studiendaten, die die Wirkung einer Host-Directed Therapy in COVID-19 zeigen
- Ergebnisse stammen aus der klinischen Studie CT-05 an 131 hospitalisierten Patienten mit COVID-19
- Die Daten zeigen, dass MetrioPharms Leitsubstanz MP1032 eine mit Remdesivir vergleichbare
InterAx Biotech Announces Being the Recipient of a Highly Competitive European Grant to Fund Drug Development and Reports Financing Highlights
InterAx Biotech AG, a pharmaceutical product development company pioneering computational pharmacology for drug discovery, announces being awarded a highly competitive and prestigious grant
SYSTRAN Translate Server Version 10 Unveiled: a Major Step Toward Increasing Business Performance of Organizations Operating Internationally
Brand new Customer Experience, advanced customization tools for higher translation quality, integrated speech translation module
PARIS, FRANCE, SAN DIEGO, CA, SEOUL, SOUTH KOREA, and
AT&T CEO: Price Increases Bring Value To Customers Through Free Added Benefits
Following is the unofficial transcript of a CNBC interview with AT&T Inc. (NYSE:T) CEO John Stankey on CNBC’s “Squawk on the Street” (M-F, 9AM-12PM ET) today, Wednesday, September 6 from the GS
Investors Push Back On Pharma Lawsuits To Thwart Medicare Negotiated Pricing
NEW YORK, NY, THURSDAY, AUGUST 31, 2023 - Today, investors released a statement voicing deep concern about lawsuits brought by pharma companies and trade groups to block the U.S. government’s
Drug Companies Impacted By Biden Rx Cost Saving Effort Boasted Of $38.7b In Profits In 2022
WASHINGTON, DC – The Biden administration has announced the first 10 prescription drugs impacted by the Inflation Reduction Act’s measures giving Medicare the power to negotiate lower prices
5 High-Yielding S&P Stocks: Is It The Right Time To Buy?
Key Points
- Dividends have historically contributed 32% of the S&P 500's total returns.
- However, high-yield stocks may indicate trouble, with declining stock prices and earnings often